Publication | Closed Access

Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial

UrologyGenitourinary CancerMedicineRenal PathologyRandomised Phase 2Cancer TreatmentOncologyRadiation Oncology